Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data

Overview of attention for article published in Frontiers in endocrinology, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 46 X posts from 41 X users, with an upper bound of 245,766 followers.

@woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm High Death rate for Kidney damage caused by glucagon-like peptide-1 receptor agonists including Semaglutide. Not unexpected. ⚰️⚰️⚰️ https://t.co/JzNNWBjiRy

Análogos GLP1: ojo a insuficiencia renal aguda como efecto adverso.

RT @DanielJDrucker: Nausea, diarrhea, vomiting, constipation and gallbladder disease are the most commonly recited AEs for GLP-1RA therapy…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 42 additional X posts.